Mutations in the p53 gene are found in up to 50% of all cancers and can not only impede its function as a tumor suppressor but also transform mutant p53 into an oncoprotein with an additional gain of function contributing to tumorigenesis (35–38). This evidence concerns the gene TP53 and neoplasm.